The iminophosphorane 3, prepared by reaction of ethyl 4-amino-5-cyano-1-phenyl-1H-pyrrole-3-carboxylate (2) with triphenylphosphine, hexachloroethane and triethylamine, reacted with equimolar quantities of aromatic isocyanates to give carbodiimides 4. Further reaction of carbodiimides 4 with various amines or phenols then gave 2,3,6,7-tetrasubstituted 4,6-dihydro-4-oxo-3H-pyrrolo[3,4-d]pyrimidin-7-carbonitrile derivatives 6 in satisfactory yields in the presence of a catalytic amount of sodium ethoxide or potassium carbonate.
Introduction
Compounds possessing a pyrrolo [3,4-d] pyrimidine nucleus possess a broad range of biological activities and have been used as potent cystic fibrosis transmembrane conductance regulator inhibitors, 1 β-site APP-cleaving enzyme 1 inhibitors 2 and A3 adenosine receptor antagonists. 3 Recent reports have also shown that some pyrrolo [3,4-d] pyrimidine derivatives may be used as inhibitors of heat shock protein 90 which could inhibit multiple pathways in human cancers. [4] [5] [6] There are many methods for the synthesis of fused pyrrolo [3,4-d] pyrimidine derivatives. One of the generally used approach is elaboration of a pyrrolo ring onto the prefabricated pyrimidine ring which bearing reactive functionalities at C-4 and C-5, [7] [8] [9] another popularly used method involved the formation of a pyrimidine ring onto the 3-aminopyrrole intermediate. [10] [11] [12] [13] [14] [15] Although some pyrrolo [3,4-d] pyrimidine derivatives have been constructed, but the synthesis of 2,3,6,7-tetrasubstituted 4,6-dihydro-4-oxo-3H-pyrrolo [3,4-d] pyrimidin-7-carbonitrile derivatives is rarely described.
Results and Discussion
The ethyl 4-amino-5-cyano-1-phenyl-1H-pyrrole-3-carboxylate 2, easily prepared by reaction of compound 1 28 with bromoacetonitrile under basic conditions, was converted into iminophosphorane 3 via reaction with triphenylphosphine, hexachloroethane and triethylamine in dry acetonitrile in good yield (Scheme 1).
Scheme 1
Iminophosphorane 3 reacted with equimolar quantities of aromatic isocyanates to form carbodiimides 4, which were allowed to further treated with amines to provide guanidine intermediates 5. In the presence of a catalytic amount of sodium ethoxide in ethanol at room temperature, intermediates 5 were easily converted into 2-amino-3-aryl-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo [3,4-d] pyrimidine-7-carbonitrile derivatives at room temperature in satisfactory yields (Scheme 2). The results are listed in Table 1 (entry 6a-6l). The cyclization reactions were achieved all in moderate to good yields whether the amines used were sterically bulky or not, and no isomers were formed such as those that have been observed in similar cases. [29] [30] [31] The structures of 2-amino-3-aryl-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo [3,4-d] pyrimidine-7-carbonitrile derivatives 6 were confirmed by their spectral data. For example, the IR spectra of 6a revealed the groups of CN and C=O absorption bands at 2215 and 1707 cm -1 , respectively.
The 1 H NMR spectrum of 6a shows two triplets at 3.15 and 3.46 ppm due to the NCH2 and OCH2, respectively. The signals attributable to the Ar-Hs and 5-H of the pyrrole ring are found at 7.18-7.57 and 7.68 ppm as multiplet and singlet, respectively. The MS spectrum of 6a shows molecular ion peak at m/z 415 with 100% abundance.
In order to extend this method of preparation of 2,3,6,7-tetrasubstituted 4,6-dihydro-4-oxo-3H-pyrrolo [3,4-d] pyrimidin-7-carbonitrile derivatives, phenols were further used to react with carbodiimides 4. When carbodiimides 4 reacted with phenols, the presence of a catalytic amount of potassium carbonate brought about the reaction to give 6 (Y = OAr) directly in good yields. The results are listed in Table 1 (entries 6m-6o). It is reasonable to assume that the reactions of carbodiimides 4 with phenols take place through an original nucleophilic addition to give the intermediates 5, which subsequently cyclized to produce 2-aryloxy-3-aryl-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo [3,4-d] pyrimidine-7-carbonitrile 6 under the basic conditions. It is noteworthy that the molecules all contain a carbonitrile group, which has been shown to be of importance in the design of biologically active heterocycles. [32] [33] [34] [35] [36] [37] 
Conclusions
In conclusion, we have developed a new and efficient way to prepare previously unreported 2,3,6,7-tetrasubstituted 4,6-dihydro-4-oxo-3H-pyrrolo[3,4-d]pyrimidin-7-carbonitrile derivatives via reaction of carbodiimides with a variety of amines and phenols. Because of the mild reaction conditions, satisfactory yields and versatile substituents, it may well serve as an efficient route to many biologically active derivatives of this nucleus substituted as indicated.
Experimental Section
General. Melting points were determined using a X-4 model apparatus and were uncorrected. MS were measured on a Finnigan Trace MS spectrometer. NMR spectra were recorded in CDCl3 on a Varian Mercury 400 or 600 spectrometer and chemical shifts () were given in ppm using (CH3)4Si as an internal reference ( = 0). IR were recorded on a PE-983 infrared spectrometer as KBr pellets with absorption in cm -1 . Elementary analyses were taken on a Vario EL III elementary analysis instrument. (2) . To a solution of (E)-ethyl 2-cyano-3-(phenylamino)acrylate 1 (2.16g, 10 mmol) in anhydrous DMF (10 mL), was added bromoacetonitrile (1.2 g, 10 mmol) at room temperature. The reaction mixture was stirred at 70 ºC for 5 h, and then equimolar quantity of sodium ethoxide in ethanol was added, then the mixture was heated to 90 ºC for 20 minutes. After the reaction was completed, the mixture was poured into water (30 (3) . To a mixture of ethyl 4-amino-5-cyano-1-phenyl-1H-pyrrole-3-carboxylate (2) (2.04 g, 8 mmol), triphenylphosphine (3.14 g, 12 mmol) and hexachloroethane (2.84 g, 12 mmol) in dry acetonitrile (40 mL), was added dropwise triethylamine (2.42 g, 24 mmol) at room temperature. After the mixture was stirred at 25 ºC for 6 h, the solvent was removed under reduced pressure, and the residue was recrystallized from ethanol to give iminophosphorane 3 as white crystals, -6j) . To a solution of iminophosphorane 3 (1.55 g, 3 mmol) in dry methylene dichloride (15 mL), an aryl isocyanate (3 mmol) was added under nitrogen at room temperature. After the reaction mixture has stood for 1 h at room temperature, the solvent was removed under reduced pressure and a mixture of ether/petroleum ether (1:2, 20 mL) was added to precipitate triphenylphosphine oxide. After filtration the solvent was removed to give carbodiimide 4, which was used directly without further purification. To the solution of 4 prepared above in methylene dichloride (10 mL), amine (3 mmol) was added. After the reaction mixture was allowed to stand for 2-6 h, the solvent was removed and anhydrous ethanol (15 mL) with several drops of sodium ethoxide in ethanol was added. The mixture was stirred for 2-4 h at room temperature. The solution was then concentrated under reduced pressure and the residual was recrystallized from methylene dichloride/ethanol to give 2-amino-3-aryl-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo[3,4-d]pyrimidine-7-carbonitrile. 2-(Dibutylamino)-3-(4-fluorophenyl)-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo[3,4-d -4-oxo-3,6-diphenyl-4,6-dihydro-3H-pyrrolo[3,4-d 2-(t-Butylamino)-4-oxo-3,6-diphenyl-4,6-dihydro-3H-pyrrolo[3,4-d 2-(t-Butylamino)-3-(4-chlorophenyl)-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo[3,4-d 6m-6o) . To the solution of carbodiimide 4 (3 mmol) prepared above in anhydrous acetonitrile (10 mL), phenol (3 mmol) and potassium carbonate (0.2 g, 1.5 mmol) were added. The mixture was stirred at 40-50 ℃ or 4-6 h. After cooling, 30 mL water was added and stir was continued until all the product was precipitated, then filtered and washed with ethanol, the residual was recrystallized from methylene dichloride/ethanol to give 6m-6o in good yields. 
Preparation of ethyl 4-amino-5-cyano-1-phenyl-1H-pyrrole-3-carboxylate

3-(4-Fluorophenyl)-2-morpholino-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo[3,4-d]pyrimidine-7-carbonitrile
2-(Dipropylamino)-3-(4-fluorophenyl)-4-oxo-6-phenyl-4,6-dihydro-3H-pyrrolo[3,4-d]pyrimidine-7-carbonitrile
2-Morpholino
